Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.
When parts of the small intestine are diseased or die, the treatment can involve surgically removing the affected tissue.